Evidence map›Paper›PMID 38862444›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[Preparation of

J Nie, Y Wu, X Han, Y Li, H Wang, H Zhang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Beyond Antibiotics: Alternative Strategies TargetingExpert reviews in molecular medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J NieSchool of Biological Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.
Y WuSchool of Biological Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.
X HanTianjin Chuangyuan Biotechnology Co., Tianjin 300457, China.
Y LiSchool of Biological Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.
H WangSchool of Biological Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.
H ZhangSchool of Biological Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo prepare a postbiotic using soybean fermentation product of

methods

results

conclusion

Indexed as

Helicobacter InfectionsHelicobacter pyloriLacticaseibacillus paracaseiAnimalsAnti-Bacterial AgentsDisease Models, AnimalFermentationGastric MucosaGlycine maxInterleukin-1betaMiceProbioticsTumor Necrosis Factor-alphaAnti-Bacterial AgentsInterleukin-1betaTumor Necrosis Factor-alphaHelicobacter pylori infectionisolationL. paracasei TK1501

Identifiers

PMID38862444
PMCPMC11166730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.